Manipal Health Enterprises IPO is a book build issue of 15,72,07,054 shares (₹9,275.22 crore). The issue is a combination of a fresh issue of 13,55,93,220 shares (₹8,000.00 crore) and an offer for sale of 2,16,13,834 shares (₹1,275.22 crore).
The Manipal Health Enterprises IPO will open on July 29, 2026, and close on July 31, 2026. The price band for the IPO is fixed at ₹560 to ₹590 per share. The minimum application size is 1 lot (25 shares), requiring a retail investor to invest at least ₹14,750 (based on the upper price band).
Manipal Health Enterprises IPO Details
| Open Date | July 29, 2026 |
| Close Date | July 31, 2026 |
| Issue Type | Book Building Issue |
| Face Value | ₹2 Equity Share |
| Price Band | ₹560 – ₹590 Per Share |
| Listing On | BSE, NSE |
| Issue Size | ₹9,275.22 Cr. (15,72,07,054 Shares) |
| Fresh Issue | ₹8,000 Cr. (13,55,93,220 Shares) |
| Offer For Sale | ₹1,275.22 Cr. (2,16,13,834 Shares) |
| EMP Discount | ₹56.00 |
| Prospectus | RHP | Anchor Investors |
Manipal Health Enterprises IPO Reservation
A total of 15,72,07,054 shares are on offer in the Manipal Health Enterprises IPO, of which 11,79,05,290 shares have been allotted to QIBs, 2,35,81,058 shares to NIIs, and 5,50,22,469 shares to RIIs.
| Category | Reservation | Shares Offered |
|---|---|---|
| QIB | 75.00% | 11,79,05,290 |
| NII | 15.00% | 2,35,81,058 |
| RII | 10.00% | 5,50,22,469 |
| Total | 100.00% | 15,72,07,054 |
Manipal Health Enterprises IPO Market Lot
Retail investors can apply for the Manipal Health Enterprises IPO with a minimum of 1 lot of 25 shares for an application amount of ₹14,750 and a maximum of 13 lots of 325 shares for an amount of ₹1,91,750.
| Application | Lot | Shares | Amount |
| Retail Minimum | 1 | 25 | ₹14,750 |
| Retail Maximum | 13 | 325 | ₹1,91,750 |
| S-HNI Minimum | 14 | 350 | ₹2,06,550 |
| S-HNI Maximum | 67 | 1,675 | ₹9,88,250 |
| B- HNI Minimum | 68 | 1,700 | ₹10,03,000 |
Key Performance Indicator
| KPI [March 31, 2026] | Value |
| Market Capitalisation | ₹77,605.68 Cr. |
| P/E Ratio | 75.93x |
| EPS | ₹7.77 |
| ROE | — |
| ROCE | 21.88% |
| RoNW | 10.57% |
| Dept/Equity | — |
| EBITDA Margin | 27.05% |
| PAT Margin | 8.87% |
| Net Assets Value | ₹72.55 |
| Price To Book Value | ₹8.13 |
Manipal Health Enterprises IPO Peer Comparison
| Company | P/E | EPS | RoNW | NAV |
| Apollo Hospitals Enterprise Limited | 66.15x | ₹135.04 | — | — |
| Fortis Healthcare Limited | 70.22x | ₹13.80 | — | — |
| Max Healthcare Institute Limited | 74.55x | ₹14.83 | — | — |
Manipal Health Enterprises IPO Dates
Manipal Health Enterprises IPO open for subscription July 29, 2026, and close date on July 31, 2026. The allotment will be finalized on July 03, 2026, and the IPO listing on July 05, 2026.
| Open Date | July 29, 2026 |
| Close Date | July 31, 2026 |
| Allotment Date | August 03, 2026 |
| Refund Date | August 04, 2026 |
| Share Credit Date | August 04, 2026 |
| Listing Date | August 05, 2026 |
Manipal Health Enterprises Company Financial Report
| Period Ended | Total Assets | Total Income | Total Expenses | Net Worth | Profit After Tax | EBITDA | Reserves and Surplus | Total Borrow |
|---|---|---|---|---|---|---|---|---|
| March 2026 | ₹24,864.50 Cr. | ₹10,520.52 Cr. | ₹9,268.42 Cr. | ₹8,440.92 Cr. | ₹916.52 Cr. | ₹2,795.94 Cr. | ₹8,204.96 Cr. | ₹10,553.43 Cr. |
| March 2025 | ₹14,072.08 Cr. | ₹8,362.79 Cr. | ₹7,134.43 Cr. | ₹5,865.66 Cr. | ₹1,081.67 Cr. | ₹2,247.07 Cr. | ₹5,788.60 Cr. | ₹4,766.83 Cr. |
| March 2024 | ₹10,818.83 Cr. | ₹6,265.17 Cr. | ₹5,340.51 Cr. | ₹4,029.22 Cr. | ₹533.20 Cr. | ₹1,776.60 Cr. | ₹3,953.59 Cr. | ₹3,943.98 Cr. |
Company Promoters
- Ranjan Ramdas Pai
- Manipal Global Health Services
- Memg International Limited
- Kangto Investments Pte. Limited
- Imperius Healthcare Investments Pte. Limited
- Kabru Investments Pte. Limited
| Holding Pre Issue | 81.43% |
| Holding Post Issue | 72.08% |
Manipal Health Enterprises IPO Lead Managers
- Kotak Mahindra Capital Company Limited
- Axis Capital Limited
- Goldman Sachs (India) Securities Private Limited
- Jefferies India Private Limited
- J.P. Morgan India Private Limited
- UBS Securities India Private Limited
- DBS Bank India Limited
Manipal Health Enterprises IPO Registrar
Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: manipal.ipo@kfintech.com
Website: https://ipostatus.kfintech.com/
Note: Check Manipal Health Enterprises IPO Allotment Status Visit IPO Investors Allotment Page And Search Your Registrar IPO Allotment Status Link. Click Here…
About Manipal Health Enterprises Limited
For your information, Manipal Health Enterprises Limited, formed in 2010 as part of the renowned Manipal Group founded by Dr. T.M.A. Pai, has established itself as one of India’s leading healthcare service providers. The company operates a large network of multi-specialty hospitals, clinics, and diagnostic centers, offering a wide range of medical care services, including tertiary and quaternary care, organ transplants, oncology, cardiology, neurology, orthopedics, and preventive healthcare. Powered by modern medical technology and staffed by experienced healthcare professionals, the company emphasizes clinical excellence, patient-centric care, and expanding medical access through strategic acquisitions, digital health initiatives, and infrastructure upgrades.
To support its extensive operations, Manipal Health relies on a large operational footprint and a strong workforce spread across the country. As of March 31, 2026, the company’s network comprises 49 hospitals with 13,037 licensed beds, as well as 21 operational clinics. This large clinical infrastructure is supported by a dedicated team of 24,240 full-time employees across corporate and medical functions, including 11,048 nurses, 6,362 paramedics, and 6,830 administrative professionals, who provide seamless patient service every day.
From a strategic perspective, Manipal Health is India’s largest multispecialty hospital group by bed capacity, with a strong presence across India and a strong brand recognition among patients and medical professionals. It has the unique advantage of being India’s only private hospital chain with leading market positions in three major metropolitan hubs—Bengaluru, Kolkata, and Pune—with a well-balanced distribution in both metro and non-metro markets. With a proven history of delivering industry-leading growth, combined with state-of-the-art infrastructure, advanced equipment, and strong financial efficiency, the company enjoys a strong position in the Indian healthcare landscape.
Company Address
Manipal Health Enterprises Limited
The Annexe,
98/2, Rustom Bagh,
HAL Airport Road,
Bengaluru, Karnataka, 560017
Phone: +9180 4936 0300
Email: legalcs@manipalhospitals.com
Website: https://www.manipalhospitals.com/
Manipal Health Enterprises IPO FAQs
What is Manipal Health Enterprises IPO?
Manipal Health Enterprises IPO is a MainBoard IPO of 15,72,07,054 equity shares of the face value of ₹2 aggregating up to ₹9,275.22 Crores. The IPO issue priced at ₹560 to ₹590 per share.
What are the open and close dates of the Manipal Health Enterprises IPO?
The IPO will open on July 29, 2026 and will close on July 31, 2026.
What is the price band for Manipal Health Enterprises IPO?
The price band for the IPO is fixed at ₹560 to ₹590 per share.
What is the issue size of the Manipal Health Enterprises IPO?
The total issue size of the IPO is ₹9,275.22 Cr., comprising both fresh issue and offer for sale (if applicable).
What is Manipal Health Enterprises IPO Minimum and Maximum Lot Size?
The minimum bid is 1 Lot, 25 Shares with ₹14,750 amount while the maximum bid is 13 Lot, 325 shares with ₹1,91,750 for the IPO.
What is Manipal Health Enterprises IPO Investors Portion?
The investors’ portion for QIB 75%, NII 15%, RII 10% for the IPO.
When will the basis of allotment for the Manipal Health Enterprises IPO be finalized?
The the IPO allotment is expected to be finalized on August 03, 2026.
When will the shares of Manipal Health Enterprises IPO get listed?
The IPO shares are expected to be listed on the BSE and NSE on August 05, 2026.
This content has been researched and written by the IPO Investors Team…
Disclaimer: Readers are strongly advised to seek guidance from a qualified financial advisor before making any investment decisions. Relying solely on the content presented here for financial choices is done entirely at the reader’s own risk.
| Thank You… |
|---|